Ross RW - Search Results

1

Multicenter phase II trial of the heat shock protein 90 inhibitor, retaspimycin hydrochloride (IPI-504), in patients with castration-resistant prostate cancer.

Oh WK, Galsky MD, Stadler WM, Srinivas S, Chu F, Bubley G, Goddard J, Dunbar J, Ross RW. Oh WK, et al. Among authors: ross rw. Urology. 2011 Sep;78(3):626-30. doi: 10.1016/j.urology.2011.04.041. Epub 2011 Jul 18. Urology. 2011. PMID: 21762967 Free PMC article. Clinical Trial.

2

Analysis of the correlation between endorectal MRI response to neoadjuvant chemotherapy and biochemical recurrence in patients with high-risk localized prostate cancer.

Galsky MD, Xie W, Nakabayashi M, Ross RW, Fennessy FM, Tempany CM, Choueiri TK, Khine K, Kantoff PW, Taplin ME, Oh WK. Galsky MD, et al. Among authors: ross rw. Prostate Cancer Prostatic Dis. 2013 Sep;16(3):266-70. doi: 10.1038/pcan.2013.15. Epub 2013 May 28. Prostate Cancer Prostatic Dis. 2013. PMID: 23712318 Free PMC article.

3

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy.

Misra D, Xie W, Regan MM, Ross RW, Lee GS, Germain D, Kantoff PW, Oh WK. Misra D, et al. Among authors: ross rw. BJU Int. 2011 Oct;108(7):1086-91. doi: 10.1111/j.1464-410X.2010.10037.x. Epub 2011 Mar 16. BJU Int. 2011. PMID: 21410629

4

Activity of dutasteride plus ketoconazole in castration-refractory prostate cancer after progression on ketoconazole alone.

Sartor O, Nakabayashi M, Taplin ME, Ross RW, Kantoff PW, Balk SP, Oh WK. Sartor O, et al. Among authors: ross rw. Clin Genitourin Cancer. 2009 Oct;7(3):E90-2. doi: 10.3816/CGC.2009.n.030. Clin Genitourin Cancer. 2009. PMID: 19815488

5

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial.

Ross RW, Galsky MD, Febbo P, Barry M, Richie JP, Xie W, Fennessy FM, Bhatt RS, Hayes J, Choueiri TK, Tempany CM, Kantoff PW, Taplin ME, Oh WK. Ross RW, et al. Cancer. 2012 Oct 1;118(19):4777-84. doi: 10.1002/cncr.27416. Epub 2012 Jan 26. Cancer. 2012. PMID: 22282219 Free PMC article. Clinical Trial.

6

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel.

Ross RW, Beer TM, Jacobus S, Bubley GJ, Taplin ME, Ryan CW, Huang J, Oh WK; Prostate Cancer Clinical Trials Consortium. Ross RW, et al. Cancer. 2008 Feb 1;112(3):521-6. doi: 10.1002/cncr.23195. Cancer. 2008. PMID: 18085595 Free article. Clinical Trial.

7

A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.

Courtney KD, Manola JB, Elfiky AA, Ross R, Oh WK, Yap JT, Van den Abbeele AD, Ryan CW, Beer TM, Loda M, Priolo C, Kantoff P, Taplin ME. Courtney KD, et al. Clin Genitourin Cancer. 2015 Apr;13(2):113-23. doi: 10.1016/j.clgc.2014.08.007. Epub 2014 Oct 22. Clin Genitourin Cancer. 2015. PMID: 25450031 Free PMC article. Clinical Trial.

8

Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer: association between Gleason score, prostate-specific antigen level, and prior ADT exposure with duration of ADT effect.

Ross RW, Xie W, Regan MM, Pomerantz M, Nakabayashi M, Daskivich TJ, Sartor O, Taplin ME, Kantoff PW, Oh WK. Ross RW, et al. Cancer. 2008 Mar 15;112(6):1247-53. doi: 10.1002/cncr.23304. Cancer. 2008. PMID: 18293426 Free article. Clinical Trial.

9

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study.

Ross RW, Galsky MD, Scher HI, Magidson J, Wassmann K, Lee GS, Katz L, Subudhi SK, Anand A, Fleisher M, Kantoff PW, Oh WK. Ross RW, et al. Lancet Oncol. 2012 Nov;13(11):1105-13. doi: 10.1016/S1470-2045(12)70263-2. Epub 2012 Oct 9. Lancet Oncol. 2012. PMID: 23059047

10

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy.

Choueiri TK, Xie W, D'Amico AV, Ross RW, Hu JC, Pomerantz M, Regan MM, Taplin ME, Kantoff PW, Sartor O, Oh WK. Choueiri TK, et al. Among authors: ross rw. Cancer. 2009 Mar 1;115(5):981-7. doi: 10.1002/cncr.24064. Cancer. 2009. PMID: 19152438 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page